US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist
  • 47.900
  • -0.790-1.62%
Close Apr 25 16:00 ET
  • 48.000
  • +0.100+0.21%
Pre 09:20 ET
97.48BMarket Cap17.87P/E (TTM)

Bristol-Myers Squibb Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-31.05%1.95B
9.60%15.19B
4.40%4.44B
17.68%5.59B
23.26%2.33B
-4.58%2.83B
6.08%13.86B
28.61%4.25B
28.86%4.75B
-16.54%1.89B
Net income from continuing operations
120.68%2.46B
-211.11%-8.93B
-95.69%76M
-37.18%1.22B
-18.92%1.68B
-625.28%-11.91B
26.71%8.04B
-12.99%1.76B
20.27%1.93B
45.35%2.08B
Operating gains losses
43.98%-214M
-56.77%-1.14B
74.50%-76M
-35.14%-300M
-128.48%-377M
-879.49%-382M
-176.34%-724M
26.96%-298M
-14.43%-222M
-298.80%-165M
Depreciation and amortization
-60.03%1.01B
-1.64%9.6B
-23.70%1.88B
6.45%2.59B
6.74%2.6B
4.24%2.53B
-5.02%9.76B
-2.26%2.46B
-5.91%2.44B
-5.85%2.43B
Deferred tax
131.36%223M
36.47%-2.09B
40.39%-791M
21.71%-256M
69.52%-331M
-29.74%-711M
-20.09%-3.29B
-112.66%-1.33B
49.30%-327M
-38.87%-1.09B
Other non cash items
-98.47%198M
1,010.22%13.47B
-99.84%1M
4.58%365M
-11.03%129M
16,320.25%12.97B
16.86%1.21B
566.67%640M
3,590.00%349M
-60.06%145M
Change In working capital
-1,044.95%-1.87B
142.32%810M
49.24%1.28B
486.60%1.71B
-39.47%-2.37B
114.56%198M
14.13%-1.91B
286.68%855M
77.44%291M
-8.07%-1.7B
-Change in receivables
-96.87%15M
126.53%264M
128.15%143M
367.61%661M
-1,467.69%-1.02B
373.71%479M
-50.08%-995M
-379.25%-508M
63.35%-247M
90.28%-65M
-Change in inventory
22.48%-169M
35.29%-486M
188.83%175M
14.84%-218M
-1,306.25%-225M
22.70%-218M
-988.41%-751M
-380.49%-197M
-1,500.00%-256M
-23.08%-16M
-Change in payables and accrued expense
-102.56%-31M
-165.68%-1.08B
-57.12%638M
-6.18%-722M
3.59%-2.2B
12.98%1.21B
69.18%-405M
310.17%1.49B
-183.33%-680M
-87.21%-2.28B
-Change in other working capital
-32.44%-1.69B
789.45%2.11B
344.44%320M
34.74%1.99B
61.65%1.08B
35.51%-1.27B
229.51%237M
-81.86%72M
34.73%1.47B
102.13%665M
Cash from discontinued investing activities
Operating cash flow
-31.05%1.95B
9.60%15.19B
4.40%4.44B
17.68%5.59B
23.26%2.33B
-4.58%2.83B
6.08%13.86B
28.61%4.25B
28.86%4.75B
-16.54%1.89B
Investing cash flow
Cash flow from continuing investing activities
97.46%-499M
-830.37%-21.35B
85.44%-196M
46.59%-219M
-300.91%-1.32B
-9,241.90%-19.62B
-116.10%-2.3B
-210.96%-1.35B
80.30%-410M
-13.84%-329M
Capital expenditure reported
8.45%-260M
-3.23%-1.25B
-14.55%-378M
5.26%-324M
-1.16%-262M
-2.16%-284M
-8.14%-1.21B
4.62%-330M
-38.46%-342M
4.78%-259M
Net business purchase and sale
100.83%165M
-7,870.00%-20.72B
184.12%286M
-17.72%-93M
-11,130.00%-1.1B
-13,396.64%-19.81B
91.28%-260M
-190.91%-340M
97.40%-79M
103.64%10M
Net investment purchase and sale
-184.52%-404M
174.82%618M
84.62%-104M
1,700.00%198M
157.50%46M
690.12%478M
-127.20%-826M
-157.05%-676M
-99.09%11M
-131.01%-80M
Cash from discontinued investing activities
Investing cash flow
97.46%-499M
-830.37%-21.35B
85.44%-196M
46.59%-219M
-300.91%-1.32B
-9,241.90%-19.62B
-116.10%-2.3B
-210.96%-1.35B
80.30%-410M
-13.84%-329M
Financing cash flow
Cash flow from continuing financing activities
-106.78%-993M
154.45%5.13B
-269.80%-1.64B
25.35%-3.85B
-85.14%-4.02B
580.13%14.64B
44.49%-9.42B
129.79%967M
-13.58%-5.16B
38.27%-2.17B
Net issuance payments of debt
-97.69%368M
2,114.04%10.1B
-119.27%-405M
-26,420.00%-2.65B
-2,158.06%-2.8B
1,155.09%15.95B
108.59%456M
1,445.59%2.1B
99.65%-10M
95.55%-124M
Net common stock issuance
----
--0
--0
--0
----
----
35.57%-5.16B
--0
-583.76%-4B
---905M
Cash dividends paid
-3.80%-1.26B
-2.51%-4.86B
-5.00%-1.22B
-2.10%-1.22B
-1.67%-1.22B
-1.34%-1.21B
-2.37%-4.74B
-1.31%-1.16B
-3.21%-1.19B
-4.09%-1.2B
Proceeds from stock option exercised by employees
-6.19%-103M
-492.59%-106M
-176.00%-19M
-60.98%16M
-111.32%-6M
-5.43%-97M
-97.26%27M
-86.03%25M
-22.64%41M
-87.35%53M
Cash from discontinued financing activities
Financing cash flow
-106.78%-993M
154.45%5.13B
-269.80%-1.64B
25.35%-3.85B
-85.14%-4.02B
580.13%14.64B
44.49%-9.42B
129.79%967M
-13.58%-5.16B
38.27%-2.17B
Net cash flow
Beginning cash position
-10.17%10.35B
23.53%11.52B
4.29%7.89B
-25.27%6.3B
3.16%9.33B
23.53%11.52B
-34.86%9.33B
-4.89%7.57B
-23.13%8.43B
-28.07%9.05B
Current changes in cash
121.59%462M
-148.16%-1.04B
-32.84%2.6B
285.59%1.52B
-390.41%-3.02B
-637.93%-2.14B
143.34%2.15B
204.24%3.87B
72.11%-819M
60.27%-615M
Effect of exchange rate changes
246.67%66M
-404.44%-137M
-288.46%-147M
302.63%77M
-175.00%-22M
-446.15%-45M
236.36%45M
-17.89%78M
42.42%-38M
88.73%-8M
End cash Position
16.51%10.88B
-10.17%10.35B
-10.17%10.35B
4.29%7.89B
-25.27%6.3B
3.16%9.33B
23.53%11.52B
23.53%11.52B
-4.89%7.57B
-23.13%8.43B
Free cash flow
-33.57%1.69B
10.20%13.94B
3.54%4.06B
19.46%5.27B
26.78%2.06B
-5.27%2.55B
5.88%12.65B
32.50%3.92B
28.17%4.41B
-18.15%1.63B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -31.05%1.95B9.60%15.19B4.40%4.44B17.68%5.59B23.26%2.33B-4.58%2.83B6.08%13.86B28.61%4.25B28.86%4.75B-16.54%1.89B
Net income from continuing operations 120.68%2.46B-211.11%-8.93B-95.69%76M-37.18%1.22B-18.92%1.68B-625.28%-11.91B26.71%8.04B-12.99%1.76B20.27%1.93B45.35%2.08B
Operating gains losses 43.98%-214M-56.77%-1.14B74.50%-76M-35.14%-300M-128.48%-377M-879.49%-382M-176.34%-724M26.96%-298M-14.43%-222M-298.80%-165M
Depreciation and amortization -60.03%1.01B-1.64%9.6B-23.70%1.88B6.45%2.59B6.74%2.6B4.24%2.53B-5.02%9.76B-2.26%2.46B-5.91%2.44B-5.85%2.43B
Deferred tax 131.36%223M36.47%-2.09B40.39%-791M21.71%-256M69.52%-331M-29.74%-711M-20.09%-3.29B-112.66%-1.33B49.30%-327M-38.87%-1.09B
Other non cash items -98.47%198M1,010.22%13.47B-99.84%1M4.58%365M-11.03%129M16,320.25%12.97B16.86%1.21B566.67%640M3,590.00%349M-60.06%145M
Change In working capital -1,044.95%-1.87B142.32%810M49.24%1.28B486.60%1.71B-39.47%-2.37B114.56%198M14.13%-1.91B286.68%855M77.44%291M-8.07%-1.7B
-Change in receivables -96.87%15M126.53%264M128.15%143M367.61%661M-1,467.69%-1.02B373.71%479M-50.08%-995M-379.25%-508M63.35%-247M90.28%-65M
-Change in inventory 22.48%-169M35.29%-486M188.83%175M14.84%-218M-1,306.25%-225M22.70%-218M-988.41%-751M-380.49%-197M-1,500.00%-256M-23.08%-16M
-Change in payables and accrued expense -102.56%-31M-165.68%-1.08B-57.12%638M-6.18%-722M3.59%-2.2B12.98%1.21B69.18%-405M310.17%1.49B-183.33%-680M-87.21%-2.28B
-Change in other working capital -32.44%-1.69B789.45%2.11B344.44%320M34.74%1.99B61.65%1.08B35.51%-1.27B229.51%237M-81.86%72M34.73%1.47B102.13%665M
Cash from discontinued investing activities
Operating cash flow -31.05%1.95B9.60%15.19B4.40%4.44B17.68%5.59B23.26%2.33B-4.58%2.83B6.08%13.86B28.61%4.25B28.86%4.75B-16.54%1.89B
Investing cash flow
Cash flow from continuing investing activities 97.46%-499M-830.37%-21.35B85.44%-196M46.59%-219M-300.91%-1.32B-9,241.90%-19.62B-116.10%-2.3B-210.96%-1.35B80.30%-410M-13.84%-329M
Capital expenditure reported 8.45%-260M-3.23%-1.25B-14.55%-378M5.26%-324M-1.16%-262M-2.16%-284M-8.14%-1.21B4.62%-330M-38.46%-342M4.78%-259M
Net business purchase and sale 100.83%165M-7,870.00%-20.72B184.12%286M-17.72%-93M-11,130.00%-1.1B-13,396.64%-19.81B91.28%-260M-190.91%-340M97.40%-79M103.64%10M
Net investment purchase and sale -184.52%-404M174.82%618M84.62%-104M1,700.00%198M157.50%46M690.12%478M-127.20%-826M-157.05%-676M-99.09%11M-131.01%-80M
Cash from discontinued investing activities
Investing cash flow 97.46%-499M-830.37%-21.35B85.44%-196M46.59%-219M-300.91%-1.32B-9,241.90%-19.62B-116.10%-2.3B-210.96%-1.35B80.30%-410M-13.84%-329M
Financing cash flow
Cash flow from continuing financing activities -106.78%-993M154.45%5.13B-269.80%-1.64B25.35%-3.85B-85.14%-4.02B580.13%14.64B44.49%-9.42B129.79%967M-13.58%-5.16B38.27%-2.17B
Net issuance payments of debt -97.69%368M2,114.04%10.1B-119.27%-405M-26,420.00%-2.65B-2,158.06%-2.8B1,155.09%15.95B108.59%456M1,445.59%2.1B99.65%-10M95.55%-124M
Net common stock issuance ------0--0--0--------35.57%-5.16B--0-583.76%-4B---905M
Cash dividends paid -3.80%-1.26B-2.51%-4.86B-5.00%-1.22B-2.10%-1.22B-1.67%-1.22B-1.34%-1.21B-2.37%-4.74B-1.31%-1.16B-3.21%-1.19B-4.09%-1.2B
Proceeds from stock option exercised by employees -6.19%-103M-492.59%-106M-176.00%-19M-60.98%16M-111.32%-6M-5.43%-97M-97.26%27M-86.03%25M-22.64%41M-87.35%53M
Cash from discontinued financing activities
Financing cash flow -106.78%-993M154.45%5.13B-269.80%-1.64B25.35%-3.85B-85.14%-4.02B580.13%14.64B44.49%-9.42B129.79%967M-13.58%-5.16B38.27%-2.17B
Net cash flow
Beginning cash position -10.17%10.35B23.53%11.52B4.29%7.89B-25.27%6.3B3.16%9.33B23.53%11.52B-34.86%9.33B-4.89%7.57B-23.13%8.43B-28.07%9.05B
Current changes in cash 121.59%462M-148.16%-1.04B-32.84%2.6B285.59%1.52B-390.41%-3.02B-637.93%-2.14B143.34%2.15B204.24%3.87B72.11%-819M60.27%-615M
Effect of exchange rate changes 246.67%66M-404.44%-137M-288.46%-147M302.63%77M-175.00%-22M-446.15%-45M236.36%45M-17.89%78M42.42%-38M88.73%-8M
End cash Position 16.51%10.88B-10.17%10.35B-10.17%10.35B4.29%7.89B-25.27%6.3B3.16%9.33B23.53%11.52B23.53%11.52B-4.89%7.57B-23.13%8.43B
Free cash flow -33.57%1.69B10.20%13.94B3.54%4.06B19.46%5.27B26.78%2.06B-5.27%2.55B5.88%12.65B32.50%3.92B28.17%4.41B-18.15%1.63B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Sample Name
Sample Code
 22.010
Sample Name
Sample Code
 8.030
Sample Name
Sample Code
 60.490
4
DexCom
DXCM
71.660
5
Workday
WDAY
239.530
Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 284.950
Sample Name
Sample Code
 368.710
Sample Name
Sample Code
 209.640
4
Meta Platforms
META
547.270
5
MARA Holdings
MARA
14.300
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 284.950
Sample Name
Sample Code
 111.010
Sample Name
Sample Code
 547.270
4
Advanced Micro Devices
AMD
96.645
5
Broadcom
AVGO
192.310
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 0.6030
Sample Name
Sample Code
 3.220
Sample Name
Sample Code
 1.890
4
BTCS Inc
BTCS
1.910
5
Canaan
CAN
0.8330
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -